Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Boxed warning of HBV risk added to Rituxan, Arezerra
Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Gray matter SWI-filtered phase and atrophy are linked to disability in MS .
Statement on a nonproprietary name adopted by the USAN Council
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Nanoparticle transport across the blood brain barrier.
Opinion: Sex inclusion in basic research drives discovery.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Biogen Idec receives notification of PDUFA date extension for PLEGRIDY™ (peginterferon beta-1a)
Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter.
Biologics-induced autoimmune diseases.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results.
Chemical and Biological Therapeutic Approaches to Neurological Disorders III
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

Pages